|Day Low/High||84.59 / 85.82|
|52 Wk Low/High||69.35 / 89.27|
Prepare for a week of Fedspeak as members prime markets for a potential interest rate hike in June.
Ahead of Fed's June meeting, investors will need to start paying close attention to Fed officials and economic data.
First serious down day in ages? Jim Cramer says it's as normal as rain; and he has an umbrella for you.
The firm gave the company an $87 price target.
Medtronic, J&J and Cardinal Health appear poised to benefit from an aging U.S. population, say investment experts.
From Abbott Labs to Wynn, these names rate checking out.
It's a wonder to me how split this market really is.
Consider how paltry the number of stocks making new highs has been.
The Cordis and Medtronic acquisitions are meant to shield Cardinal from the pricing swings of drug distribution.
Cardinal Health had reported that it expects full year adjusted earnings on the lower end of its guidance.
Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.
Jim Cramer maintains this rally is fueled by the strong performance of U.S. companies, but says it's worth assessing stock market valuations.
Ori Hadomi, CEO of Mazor Robotics, tells Jim Cramer about growth opportunities in health technology.
IBM's busted turnaround and difficult transition story shaved more than 50 points off the Dow, says Jim Cramer.
Cardinal bought Medtronic's medical supplies businesses for $6.1 billion.
From Aetna to United Technologies, these names are hot.
Their overseas business has been carrying them.
Stocks give back gains on Thursday afternoon as Donald Trump prepares to meet with China's President Xi Jinping for a two-day summit.
Stocks creep cautiously higher ahead of the U.S. jobs report for March on Friday and a possibly contentious meeting between Donald Trump and China's President Xi Jinping.
Stock futures are higher Thursday as investors remain cautious ahead of the U.S. jobs report on Friday and meeting between Donald Trump and China's Xi Jinping.
Medtronic is said to be close to a $6 billion deal to sell its medical supplies unit.
U.S. stock futures turn higher Thursday after the Fed commits to further monetary tightening in 2017. Investors also are anticipating the meeting between Donald Trump and Chinese leader Xi Jinping.
Intel added executives from Medtronic and Boeing to its board of directors.
The tie-up between Big Blue and the cloud CRM software leader highlights IBM's unique AI position and strengths.
When it comes to AI solutions meant for specific industries, IBM has a lot of expertise and the ability to cast a broad net.
This patient-monitoring device-maker has plenty of room for growth.
There are nearly too many surging sectors to count.